Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8686155 Aurora kinase modulators and method of use

Patent 8686155 was granted and assigned to Amgen on April, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86861550

Patent Inventor Names

Laurie Schenkel0

Philip R. Olivieri0

Victor J. Cee0

Date of Patent

April 1, 2014

Patent Application Number

131713550

Date Filed

June 28, 2011

Patent Citations Received

‌

US Patent 11925651 TEAD inhibitors and uses thereof

‌

US Patent 11760728 Tead inhibitors and uses thereof

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

The present invention relates to chemical compounds having a general formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8686155 Aurora kinase modulators and method of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API